33
https://pubmed.ncbi.nlm.nih.gov/38116572
The CRISPR-Cas9 system combined with dCas9-dnmt3a was successful in reducing hTERT expression and inducing apoptosis in glioma cancer cells.
“CRISPR-Cas9 and dCas9-dnmt3a System Reduces hTERT Expression and Induces Apoptosis in Glioma Cancer Cells”
